glp-1 obesity drug news october 2025 Market Size to Hit USD 66.57 Billion by 2035 Outlook for Obesity in 2026:
Description
Scientific understanding, clinical evidence, regulatory positions, and treatment recommendations may change as new research becomes available
The axis represents time in weeks
The landscape of medical weight loss has just shifted dramatically
doi: 10.1017/S0954422418000136 43 LiYZDi CristofanoAWooM
Ethics declarations Authors relationships and activities MT is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, MA
Focus on the influence of GLP-1-RA (e.g., Exenatide, Semaglutide, Liraglutide) on hMSC
